4,200 Shares in Canopy Growth Corp (CGC) Purchased by Usca Ria LLC
Usca Ria LLC purchased a new stake in Canopy Growth Corp (NYSE:CGC) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,200 shares of the marijuana producer’s stock, valued at approximately $204,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Epstein & White Financial LLC bought a new position in shares of Canopy Growth during the second quarter worth $244,000. Cornerstone Wealth Management LLC bought a new position in shares of Canopy Growth during the second quarter worth $350,000. Creative Planning bought a new position in shares of Canopy Growth during the second quarter worth $932,000. K.J. Harrison & Partners Inc bought a new position in shares of Canopy Growth during the second quarter worth $639,000. Finally, TD Asset Management Inc. bought a new position in shares of Canopy Growth during the second quarter worth $19,252,000. 7.44% of the stock is owned by hedge funds and other institutional investors.
A number of equities analysts recently weighed in on CGC shares. Canaccord Genuity upgraded shares of Canopy Growth from a “hold” rating to a “buy” rating in a research report on Thursday, August 16th. Zacks Investment Research lowered shares of Canopy Growth from a “hold” rating to a “sell” rating in a research report on Tuesday, August 28th. Cann started coverage on shares of Canopy Growth in a research report on Friday, October 12th. They set a “sell” rating and a $30.00 target price for the company. They noted that the move was a valuation call. Benchmark started coverage on shares of Canopy Growth in a research report on Tuesday, September 25th. They set a “buy” rating for the company. Finally, Scotiabank started coverage on shares of Canopy Growth in a research report on Wednesday, October 17th. They set a “hold” rating and a $61.00 target price for the company. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $36.67.
Canopy Growth (NYSE:CGC) last released its quarterly earnings results on Tuesday, August 14th. The marijuana producer reported ($0.31) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.19). The business had revenue of $20.09 million for the quarter, compared to analysts’ expectations of $21.04 million. Canopy Growth had a negative net margin of 159.94% and a negative return on equity of 12.47%. On average, equities research analysts predict that Canopy Growth Corp will post -0.41 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “4,200 Shares in Canopy Growth Corp (CGC) Purchased by Usca Ria LLC” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2018/11/10/4200-shares-in-canopy-growth-corp-cgc-purchased-by-usca-ria-llc.html.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.
Want to see what other hedge funds are holding CGC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Canopy Growth Corp (NYSE:CGC).
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.